The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
To increase health in elderly at risk to become frail we need to understand the biological cause of their frailty and increase resilience to the detrimental consequences of aging. Importantly, a substantial number of elderly is remarkably fit, and appear resilient to many aspects of the aging process. This demonstrates that the human body in principle can defy many of the debilitating aspects of aging.
During the last decade significant progress has been made towards identifying individual mechanisms that contribute to the demise of molecules, cells, and organisms during the aging process. Although we still do not know to what extent aging is modifiable, for the first time the prospect of increasing resilience to aspects of the aging process by targeted interventions seems now feasible.
Is to identify critical molecular interactions associated with frailty, and elucidating the molecular, cellular and organismal origin of heterogeneity of the aging process. This approach will allow us to develop interventions aimed to increase resilience, and add life to lifetime.
We focus on (the interactions between) 4 key aging pathways that have individually shown to be modifiable: the (epi-)genome, the protein-quality machinery, metabolism, and regeneration and senescence.
Collectively, these will allow for the rational development of individualized treatment strategies aimed to prevent, delay, or reverse frailty in vulnerable elderly.
More information visit the: European Institute for the Biology of Ageing and Biomedical Sciences of Cells and Systems.